MARCKS and melanoma: The increases in the levels of phospho-MARCKS and total MARCKS in A375-R2 melanoma cells were significantly reduced after 48 h of transfection with the MARCKS-targeting shRNA vector and almost completely abolished after 144 h (Figure S7A–C).